Pharmaceutical Commerce: Alternative funding programs threaten patient access
Information about this website: Following the March 2026 merger of Patient Advocate Foundation and the PAN Foundation, this website is now a part of Patient Advocate Foundation and remains active during our website transition.
Where to find information during our transition:
- About the merged organization: uniting.patientadvocate.org
- Financial assistance: totalassist.org
- Additional direct patient services and resources: patientadvocate.org
- Education: panfoundation.org and education.patientadvocate.org
- Clinical trials education: clinicaltrials.panfoundation.org
- Advocacy: npaf.org
- Research: patientinsightinstitute.org
A national poll by the PAN Foundation’s Center for Patient Research, and a primer about how alternative funding programs work, was featured in Pharmaceutical Commerce. The PAN study revealed that more than half of insured adults with commercial insurance have been told by their health insurance plan that medications for their chronic or rare disease were no longer covered.
- Read the article in Pharmaceutical Commerce
- Explore our research in PAN’s Center for Patient Research